Twitter Beğeni Hilesi

At the 2024 UCLA Visionary Ball, Dr. Linda Liau was able to introduce 2 patients who were treated with $NWBO #DCVax-L & are now long-term survivors of Glioblastoma (GBM). Shenell Malloy has survived for 5 years & Brad Silver has survived for 21 years. When you hear & read the

It is encouraging to see American Society of Gene & Cell Therapy (ASGT) predict MHRA will approve $NWBO #DCVax-L in the UK by 9/30/2024 & EverNorth (Cigna Health) predict FDA will approve DCVax in the US in 2025. This is good news & it provide hope for solid tumor cancer

UK Gov Outlook on $NWBO #DCVax-L (Murcidencel). The "Likely Availability NHS" is listed as 2025. 🙏 The DCVax® Platform For All Solid Tumor Cancers 💪 #glioblastoma #gbm #CancerMoonshot @potus @flotus Vice President Kamala Harris sps.nhs.uk/wp-content/upl… nice.org.uk/guidance/indev… reddit.com/r/NWBO/comment…

#Flaskworks "Patented Case" on August 21, 2024: US17/673,443 - "Systems and methods for cell culturing" patentscope.wipo.int/search/en/deta… $NWBO

This is how you lose credibility in a court case. Merrill Lynch Appears to have forgotten to disclose there is a team and computer program tasked with monitoring spoofing in a civil spoofing case accusing Merrill Lynch (and multiple other market makers) of failing to have

Actimize claims spoofing is "not difficult" to detect. Were there documented incidences of Merrill Lynch ignoring spoofing warnings? Why was Merrill Lynch trying to hide the fact that they used Actimize and employed an entire compliance team? Questions I'm sure that will be

Is this why Virtu Financial is eager to get Nasdaq to delist stocks under $1.00? $NWBO has a promising vaccine for brain cancer treatment. Yet its stock price has been driven down to .38. That makes it more difficult for a company to get the money it needs to do research

A Progressive Libertarian Your unsupported opinions of the $NWBO spoofing case means absolutely nothing in the grand scheme of things. What does matter? The judge's well reasoned opinion. "The FAC contains particularized factual allegations evincing all these indicia of spoofing."

This article published in 2017, by Drs. Linda Liau, Robert Prins, Timothy Cloughesy & et al, was about an animal (mice) study that combined $NWBO #DCVax-L + Keytruda (Pembrolizumab, Merck). It was 1 of the first studies to show that ATL-DC (autologous tumor lysate-pulsed DC

Big Pharma (BP) wants to hold on to making $billions in profits from treating cancer patients with highly toxic chemo instead of true immunotherapy like $NWBO #DCVax. They are investing billions in ADCs, another form of chemo: investorshub.advfn.com/boards/read_ms…

Breaking Through Supply Chain Bottlenecks in CGT on September 25, 2024. fiercebiotech.com/premium/webina… $NWBO

$NWBO Patent granted on September 2, 2024 - 🇮🇱 IL256522 - "Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response" patentscope.wipo.int/search/en/deta…

Thanks to the life-saving care provided by Dr. Linda Liau, Chair of UCLA Neurosurgery, Maui attorney Jamil Newirth has turned his fight against #glioblastoma - the deadliest form of brain cancer - into hope for others. Learn more about Jamil's story here: bit.ly/4cBaQEU

Unfortunately there aren’t many neuro-oncologists & neurosurgeons, who have treated newly diagnosed (nGBM) & recurrent Glioblastoma (rGBM) patients, who can truthfully make this statement. Dr. Linda Liau, who has treated hundreds of nGBM & rGBM patients, with $NWBO #DCVax-L can

Thanks d_stock! As you know J. Kelly Ganjei is the CEO of AmplifyBio & he’s the past CEO of Cognate Bioservices. He’s also listed as 1 of the inventors on #DCVax-L + Checkpoint Inhibitors combination patents, along with the inventors at UCLA & $NWBO: investorshub.advfn.com/boards/read_ms…

There are a lot of interconnections & past relationships. J. Kelly Ganjei used to also work for Toucan Capital & Cognate Bioservices. Cognate manufactured #DCVax-L for the Phase 3 trial. Toucan Capital owned Cognate & now owns Advent Bioservices. $NWBO owns the Sawston facility.

MHRA UPDATE! 10/09/2024 (September 10, 2024) UK MIA 54923 ADVENT BIOSERVICES LTD MANUFACTURING OPERATIONS (according to part 1) $nwbo #dcvax #glioblastoma #gbm cms.mhra.gov.uk/mhra/mia/uk-mi…

Another Clear M.R.I With Dr. Cloughesy. NWBO DCVax-L The Future of Personalized Immunotherapy. Lisa🇺🇸🇺🇦 annie post Gregory Zivic, MD Patricia Elvir Pons MD Last Week Tonight stackingsilver UCLA